Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603441 · ClinicalTrials.gov registry record
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
A clinical trial of Obstructive Sleep Apnea of Adult, sponsored by Stanford University.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06603441 is a study of Obstructive Sleep Apnea of Adult that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 150 participants, below the 506-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06603441, a study of Obstructive Sleep Apnea of Adult, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Samsung Galaxy Watch
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06603441
The ClinicalTrials.gov registry entry for NCT06603441 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 506-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (70% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obstructive Sleep Apnea of Adult appearing as the primary indexed condition, and to 1 intervention - of which Samsung Galaxy Watch is the first listed.
NCT06603441 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06603441 about?
NCT06603441 is a clinical study titled "Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea". The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
What is the current status of trial NCT06603441?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2024-12-17. Estimated completion is 2026-03.
What conditions does trial NCT06603441 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea of Adult.
What interventions are being tested in trial NCT06603441?
The interventions under investigation include: Samsung Galaxy Watch (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06603441?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06603441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea of Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
RECRUITING · NA
-
A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea
RECRUITING
-
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
RECRUITING · NA
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Vascular Endothelial Dysfunction in Sleep Apnea
RECRUITING · Phase 1
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.